Novartis AG (NVS)
131.01
+0.84
(+0.65%)
USD |
NYSE |
Dec 09, 16:00
131.84
+0.83
(+0.63%)
Pre-Market: 08:52
Novartis Market Cap: 251.38B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Roche Holding AG | 310.25B |
| Regeneron Pharmaceuticals, Inc. | 72.79B |
| Avidity Biosciences, Inc. | 10.74B |
| Monte Rosa Therapeutics, Inc. | 1.106B |
| Tourmaline Bio, Inc. | 1.233B |
Market Cap Related Metrics
| PE Ratio | 17.87 |
| PS Ratio | 4.742 |
| Price to Book Value | 5.671 |
| Price to Free Cash Flow | 15.06 |
| Price | 131.01 |
| Earnings Yield | 5.60% |
| Operating PE Ratio | 14.94 |
| Normalized PE Ratio | 16.97 |